Erythropoietin Market 2026–2030 driven by anemia treatment demand

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Erythropoietin (EPO) Market From 2026 To 2030?

The erythropoietin (epo) market size has seen rapid expansion in recent years. It is anticipated to increase from $19.25 billion in 2025 to $21.46 billion in 2026, at a compound annual growth rate (CAGR) of 11.5%. The historical growth of this market can be attributed to the rising prevalence of anemia, an increasing incidence of chronic kidney disease, the established clinical effectiveness of epo therapy, advancements in recombinant biologic manufacturing, and the growing use of epo in cancer-related anemia management.

The erythropoietin (epo) market is projected for substantial expansion over the coming years. This market is set to reach $35.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.0%. This anticipated growth is driven by factors such as a surge in biosimilar approvals, an expanding elderly demographic, a rise in the worldwide volume of dialysis patients, advancements in sustained-release epo medications, and enhanced availability of biologic therapies in developing economies. Key trends anticipated during this period encompass the broader application of erythropoietin in chronic kidney disease, increasing acceptance of biosimilar erythropoietin treatments, a heightened need for long-acting epo formulations, greater utilization of epo in oncology supportive care, and more stringent regulatory control over epo safety and dosing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp

What Major Drivers Are Influencing Demand In The Erythropoietin (EPO) Market?

The erythropoietin market is projected to experience increased demand in the coming years due to the escalating occurrence of chronic kidney diseases. The rising instances of chronic kidney disease necessitate erythropoietin administration, which aids in red blood cell formation to enhance immunity. For instance, in 2023, figures from the Centers for Disease Control, a US-based federal agency, estimated that around 14% of U.S. adults, equivalent to approximately 35.5 million people, are affected by chronic kidney disease (CKD). Consequently, this escalating incidence of chronic kidney diseases is driving up the demand for erythropoietin, thereby boosting market revenues.

Which Segments Are Included In The Analysis Of The Erythropoietin (EPO) Market?

The erythropoietin (epo) market covered in this report is segmented –

1) By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Other Products

2) By Drug Class: Biologist, Biosimilar

3) By Application: Cancer, Hematology, Renal Diseases, Neurology, Other Applications

Subsegments:

1) By Epoetin-Alfa: Epoetin-Alfa, Epoetin-Alfa Biosimilars

2) By Epoetin-Beta: Epoetin-Beta, Epoetin-Beta Biosimilars

3) By Darbepoetin-Alfa: Darbepoetin-Alfa, Darbepoetin-Alfa Biosimilars

4) By Other Products: Peginesatide, Novel EPO Products

Which Trends Are Impacting The Growth Of The Erythropoietin (EPO) Market?

Leading corporations in the erythropoietin market are concentrating on launching oral medications, which provide more convenient choices than conventional injectable treatments. This initiative aims to enhance patient comfort, adherence, and flexibility in treatment, particularly for individuals managing long-term conditions such as anemia in chronic kidney disease (CKD). As an illustration, in February 2023, GlaxoSmithKline (GSK), a UK-based multinational pharmaceutical and biotechnology company, released Jesduvroq (daprodustat) tablets. This oral medicine aids in increasing erythropoietin levels, thereby assisting in the management of anemia in CKD patients by maintaining hemoglobin levels within a specified range. Jesduvroq’s core purpose is to offer a more convenient option to injectable therapies, thereby improving patient comfort, compliance, and treatment flexibility for dialysis patients.

Which Key Industry Participants Are Active In The Erythropoietin (EPO) Market?

Major companies operating in the erythropoietin (epo) market are Amgen Inc., Roche Holding AG, Pfizer Inc., Merck & Co., Teva Pharmaceutical Industries Ltd., 3SBio Inc., Celltrion Inc., Intas Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Reliance Life Sciences Pvt. Ltd., Biocon Limited, Chugai Pharmaceutical Co., Kyowa Kirin Co. Ltd., Apotex Inc., CJ Healthcare Corp., STADA Arzneimittel AG, Hospira Inc., Sandoz International GmbH, Torrent Pharmaceuticals Ltd., LG Life Sciences Ltd., Sanofi S.A., Bayer AG, Hikma Pharmaceuticals.

Read the full erythropoietin (epo) market report here:

https://www.thebusinessresearchcompany.com/report/erythropoietins-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Erythropoietin (EPO) Market?

North America was the largest region in the erythropoietin (EPO) market in 2025. The Middle East is expected to be the fastest growing region in the global erythropoietin (EPO) market analysis in the forecast period. The regions covered in the erythropoietin (epo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Erythropoietin (EPO) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3436&type=smp

Browse Through More Reports Similar to the Global Erythropoietin (EPO) Market 2026, By The Business Research Company

Protein Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Therapeutic Proteins Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

Hematology Analyzers And Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795